Bimatoprost

贝美前列素

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameBimatoprost
Drug Alias NameGlashVista贝美前列腺素比马前列素Bimatoprost Sustained-Release ImplantGlash Vista Cutaneous Solution +[16] 
ClassificationSmall molecules
Mechanisms of ActionProstanoid receptor agonists
TargetsProstanoid receptor
Therapy Area/IndicationsBurnsCicatrix, HypertrophicCicatrix +[16] 
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2001/03/16
Country/TerritoryCzechiaBelgiumBulgaria +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesSpyglass Pharma IncLaboratoires Thea SASAllergan Plc +[10] 
Inactive CompaniesAmneal Eu LtdForsight Vision5 IncDuke University +[10] 
Active IndicationsBurnsCicatrix, HypertrophicCicatrix +[12] 
Inactive IndicationsAlopeciaCutis LaxaMigraine Disorders +[4] 

Other Information

ATC CodeS01EE03
Related LinksWikipediaDrugBankKEGG